The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.
Claire Scanlan
Advertisement
Claire Scanlan is process development scientist at EMD Millipore, 290 Concord Road, Billerica, MA 01821.
Articles by Claire Scanlan
Antibody fragments pose unique challenges in recovery, purification, and formulation.
Advertisement
Latest Updated Articles
Downstream Purification and Formulation of Fab Antibody FragmentsPublished: January 1st 2014 | Updated:
Bioprocessing Technology Trends of RNA-Based Therapeutics and VaccinesPublished: July 1st 2016 | Updated:
Advertisement
Advertisement
